Skip to content

CANNAPHARMARX, INC.: 10-Q filed 2015-08-12

What CANNAPHARMARX, INC. reported in its quarterly report filed 2015-08-12 (fiscal Q2 2015): 23 published measures, 73 facts as tagged in accession 0001193125-15-288206.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-12
Fiscal period
fiscal Q2 2015
Accession
0001193125-15-288206 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CANNAPHARMARX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-301,093,266USD
At 2014-12-311,797,042USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-30687,272USD
At 2014-12-312,085,272USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30405,994USD
At 2014-12-31-288,230USD
At 2013-12-31-292,034USD
At 2012-12-31-197,628USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-30938,397USD
At 2014-12-311,605,239USD
At 2014-06-301,978,862USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,127,086USD91
2015-01-01 to 2015-06-30-5,784,557USD181
2014-01-01 to 2014-12-31-3,978,433USD365
2014-04-01 to 2014-06-30-153,138USD91
2014-01-01 to 2014-06-30-178,776USD181
2013-01-01 to 2013-12-31-94,406USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-302,078USD181
2014-01-01 to 2015-06-30102,800USD546
2015-01-01 to 2015-03-312,078USD90
2014-01-01 to 2014-12-31100,721USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-300USD91
2015-01-01 to 2015-06-300USD181
2014-04-01 to 2014-06-300USD91
2014-01-01 to 2014-06-300USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-26,929,905USD
At 2014-12-31-21,145,348USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-3093,452USD
At 2014-12-3197,701USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-06-303,135,968USD91
2015-01-01 to 2015-06-304,075,536USD181
2014-04-01 to 2014-06-300USD91
2014-01-01 to 2014-06-300USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,126,310USD91
2015-01-01 to 2015-06-30-5,783,004USD181
2014-04-01 to 2014-06-30-153,159USD91
2014-01-01 to 2014-06-30-174,267USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-30999,814USD
At 2014-12-311,649,341USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-30632,272USD
At 2014-12-311,940,272USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-304,126,310USD91
2015-01-01 to 2015-06-305,783,004USD181
2014-04-01 to 2014-06-30153,159USD91
2014-01-01 to 2014-06-30174,267USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30161,721USD91
2015-01-01 to 2015-06-30322,562USD181
2014-04-01 to 2014-06-3037,201USD91
2014-01-01 to 2014-06-3037,201USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3017,959,621shares
At 2014-12-3117,374,407shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-06-309,348USD
At 2014-12-319,348USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2015-06-300USD
At 2014-12-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,127,086USD91
2015-01-01 to 2015-06-30-5,784,557USD181
2014-04-01 to 2014-06-30-153,138USD91
2014-01-01 to 2014-06-30-178,776USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30828,621USD91
2015-01-01 to 2015-06-301,384,906USD181
2014-04-01 to 2014-06-30115,958USD91
2014-01-01 to 2014-06-30137,066USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-04-01 to 2015-06-303,192USD91
2015-01-01 to 2015-06-306,327USD181
2014-04-01 to 2014-06-300USD91
2014-01-01 to 2014-06-300USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-776USD91
2015-01-01 to 2015-06-30-1,553USD181
2014-04-01 to 2014-06-3021USD91
2014-01-01 to 2014-06-30-4,509USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-01-01 to 2015-06-30804,500USD181
2014-01-01 to 2014-06-302,378,000USD181

Inspect the source

Entity
CANNAPHARMARX, INC. / CIK 0001081938
Captured
2026-09-20T05:20:43.396Z
SEC response SHA-256
5d42938250dbbcfa19092cae39e1ddd591085d080af4dafac930684703fc6a67

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001081938.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))